• Pragmatic Trials Testing ‘Passive Digital Marker’ For Detecting Dementia

    Clinical Research News | Research scientists at Indiana University–Purdue University Indianapolis and Regenstrief Institute have developed a “passive digital marker” (PDM), powered by machine learning, to help identify people at risk for Alzheimer’s disease and related dementias at an earlier stage in primary care settings. Application of the PDM will now be tested in the real world in a pair of pragmatic randomized controlled trials.

    Feb 22, 2023
  • AI Transforming Real-World Clinical Development

    Clinical Research News | Artificial intelligence and machine learning solutions bringing tangible improvements to clinical trial conduct took center stage at the recent Summit for Clinical Ops Executives, where a succession of companies—including Pfizer, AbbVie, and IQVIA—took to the podium to share their use cases and road to success.

    Feb 21, 2023
  • Follow the Money: Whole Blood Product Transfuses Soldiers in Active Combat, UC Davis Launches Psychedelics and Neurotherapeutics Research Institute, More

    Clinical Research News | Funding for various metabolomic research advancements, therapeutic developments, and precision medicine applications, a new federally funded research program testing the safety and efficacy of tools for trauma victims with numerous complex injuries, accelerating research across the field of synthetic biology, and more.

    Feb 21, 2023
  • Precision Oncology: Targeting the Ongoing Clinical Staffing Challenges

    Clinical Research News | Recent staffing challenges spurred by the COVID-19 pandemic have played a sustained, negative role in clinical trial workflows. However, through precision technology, healthcare providers can decrease turnover rates and reduce the major ongoing clinical trial workflow challenges resulting from lower personnel.

    Feb 17, 2023
  • A Long Time Coming On Digital Endpoints

    Clinical Research News | Efforts to use digital endpoints to modernize clinical trials have been slowed by an assortment of challenges. But the field will be getting a big push in the right direction in another few months when the first hard evidence will be published demonstrating digital endpoints can live up to their promise of delivering smaller, speedier trials.

    Feb 16, 2023
  • Merck Outlines Structure of Saama Partnership on AI for Clinical Data

    Clinical Research News | AI for clinical data was the subject of several presentations at the recent Summit for Clinical Ops Executives event in Orlando, Fla. SCOPE speakers from across big pharma shared their use cases in applying artificial intelligence and machine learning to various parts of the clinical research process.

    Feb 15, 2023
  • Janssen Redefining Decentralized Clinical Trials With Retail And Mobile Clinics

    Clinical Research News | Janssen Pharmaceuticals (a Johnson & Johnson company) is customizing the way it conducts clinical trials, utilizing retail clinics on their own or with an affiliate healthcare system as well as mobile clinics stationed outside long-term care facilities in the community. This will enable study teams to choose the model that best suits a trial and participants to “choose the adventure” they most prefer.

    Feb 14, 2023
  • Sponsors Asked To Seize The Day On ‘Wisdom Of The Crowd’ Study Solutions

    Clinical Research News | At this week’s Summit for Clinical Ops Executives, Genentech’s Virginia Nido delivered a call to action to her industry peers, asking them to learn the landscape of collaboratively developed clinical trials solutions and start using them.

    Feb 10, 2023
  • SCOPE Awards for Anju, EmVenio, Medidata, StudyKIK, uMotif

    Clinical Research News | ORLANDO—Clinical Research News and ClinEco announced the 2023 SCOPE Best of Show awards yesterday at SCOPE. Products from Anju Software, EmVenio, Medidata, StudyKIK, and uMotif took top honors.

    Feb 9, 2023